Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium Pretreatment for Succinylcholine-Induced Myalgia in ERCP
NCT04581395Phase 3Completed
- Sponsor
- Indiana University
- Start
- Oct 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rocuronium in myalgia, sponsored by Indiana University. Started Oct 2020; status: completed.
02
Drugs
rocuronium
03
Conditions
myalgia
Beyond the preview
Go deeper on NCT04581395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04581395.